Pfiz­er vet Ger­mano makes quick ex­it from In­trex­on as hands-on bil­lion­aire Kirk re­or­ga­nizes biotech

When Geno Ger­mano left a se­nior post at Pfiz­er and lat­er signed on as pres­i­dent of In­trex­on 10 months ago, he start­ed down a path that he was told led straight to the CEO’s job. In­stead, he wound up at the ex­it door on Fri­day, leav­ing bil­lion­aire Ran­dal “RJ” Kirk at the helm of the com­pa­ny he found­ed, re­or­ga­niz­ing the com­plex biotech side of the busi­ness.

Ger­mano had been head of the glob­al phar­ma busi­ness at Pfiz­er when he was sud­den­ly odd man out in a planned merg­er with Al­ler­gan, which al­so ul­ti­mate­ly nev­er hap­pened. Kirk wel­comed him with open arms, telling the world that Ger­mano would be the next chief for day-to-day op­er­a­tions $XON as he stepped up to the ex­ec­u­tive chair­man’s role.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER